According to a report by The New York Times, an internal memo from the U.S. Food and Drug Administration (FDA) indicates that at least ten children may have died due to side effects associated with COVID-19 vaccines, reigniting discussions about vaccine safety.
The memo, authored by the FDA's chief medical and scientific officer, Vinay Prasad, suggests that myocarditis could be a possible cause of these fatalities. However, the document did not provide specific details regarding the ages of the children, their prior health conditions, or the vaccine manufacturers involved.
Prasad, known for his candid critiques of vaccine and mask mandates during the pandemic, described the findings as "a profound revelation" and announced that the agency would tighten monitoring standards for vaccine approvals, including the need for more comprehensive randomized studies across all age groups.
The report also mentioned that the vaccine advisory committee of the Centers for Disease Control and Prevention (CDC) is expected to hold a meeting in the coming days, as the memo is likely to prompt a broader discussion on vaccine policy and the monitoring of rare side effects.
This controversy arises as U.S. Health Secretary Robert Kennedy Jr. re-evaluates state policy on COVID-19 vaccines, proposing to limit access to individuals over 65 or those with existing health issues. Kennedy has emerged as a prominent voice against vaccines and has previously linked them to disorders such as autism.
Throughout the administrations of Donald Trump and Joe Biden, health authorities have maintained strong support for vaccines, viewing them as essential tools for saving lives and reducing mortality. However, the latest internal memo has brought the discussion back to square one, raising new questions about the balance between public health needs and scientific safety requirements.